Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Van Steirteghem, A.
Right arrow Articles by Devroey, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Van Steirteghem, A.
Right arrow Articles by Devroey, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 13, No. suppl_1, pp. 134-142, 1998
© 1998 European Society of Human Reproduction and Embryology

Results of intracytoplasmic sperm injection with ejaculated, fresh and frozen–thawed epididymal and testicular spermatozoa

A. Van Steirteghem1, P. Nagy, H. Joris, C. Janssenswillen, C. Staessen, G. Verheyen, M. Camus, H. Tournaye and P. Devroey

Centre for Reproductive Medicine, Medical School and University Hospital, Dutch-speaking Brussels Free University (Vrije Universiteit Brussel) Belgium

Correspondence: 1To whom correspondence should be addressed at: Centre for Reproductive Medicine, Academisch Ziekenhuis VUB, Laarbeeklaan 101, B-1090 Brussels, Belgium

Over the past 5 years, intracytoplasmic sperm injection (ICSI) has been developed to alleviate severe long-standing andrological infertility in couples who could not be helped by standard in-vitro fertilization (IVF), or who could not undergo IVF because too few motile and morphologically normal spermatozoa were present in the ejaculate. ICSI can also be carried out with fresh and frozen–thawed epididymal spermatozoa from patients with obstructive azoospermia and with testicular spermatozoa from most patients with obstructive azoospermia and from some patients with non-obstructive azoospermia. This review reports the results of 5 years of ICSI practice (1991–1995) at the Brussels Free University Centre for Reproductive Medicine, including selection of patients, oocyte and spermatozoa for ICSI, ICSI procedures and its assessment. ICSI was performed in 97% of the 4688 planned treatment cycles. Ejaculated spermatozoa were used in 88% of the cycles, epididymal spermatozoa in 5% of the cycles and testicular spermatozoa in 7% of the cycles. ICSI was performed on 48 393 metaphase II oocytes. Of these, 89.5% were morphologically intact, and 70.9% of the intact oocytes were normally fertilized; 64.9% of the two-pronuclear oocytes developed after a further 24 h of in-vitro culture into cleaved embryos, which were transferred or cryopreserved for subsequent use. After transfer of fresh embryos, the percentage of cycles with positive serum human chorionic gonadotrophin was 36.2% per transfer and the percentage of deliveries was 27.0% per transfer. The performance of ICSI with regard to damage, pronuclear status, embryo development and transfer was analysed separately for the four different types of spermatozoa used: fresh ejaculated, epididymal and testicular as well as frozen–thawed epididymal spermatozoa.

Key words: cryopreservation/embryos/epididymis/ICSI/spermatozoa/testis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
I. Liebaers, S. Desmyttere, W. Verpoest, M. De Rycke, C. Staessen, K. Sermon, P. Devroey, P. Haentjens, and M. Bonduelle
Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis
Hum. Reprod., August 27, 2009; (2009) dep298v1.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. Oehninger
Strategies for Fertility Preservation in Female and Male Cancer Survivors
Reproductive Sciences, May 1, 2005; 12(4): 222 - 231.
[Abstract] [PDF]


Home page
J AndrolHome page
J. Tesarik and C. Mendoza
Using the Male Gamete for Assisted Reproduction: Past, Present, and Future
J Androl, May 1, 2003; 24(3): 317 - 328.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.